Hawkeye Systems, Inc. (OTCQB: HWKE), a technology holding company focused on pandemic management products and services, is pleased to announce an update on the progress of its partnership with DemeTECH, a U.S.-based manufacturer of suture and other medical devices and products. “In this partnership we started with the creation of a surgical mask first, which has tested out as a level three ASTM mask, and once we (DemeTECH) got FDA approval for that mask, then turned to n95s which have been submitted for NIOSH approval,” said Luis Arguello, Jr, SVP DemeTECH.
Hawkeye Systems Chief Executive Officer, Corby Marshall, stated, “The recent testing data gives us great confidence in the quality and efficacy of the masks being manufactured by our partner DemeTECH. We are excited to expand the relationship and we have submitted samples for NIOSH certification. We hope for improvement in the country’s challenges regarding the current Pandemic but are prepared to bring supply which does not require manufacture in a foreign country, which won’t have to go through the complications of logistics and customs during a pandemic, and which can ship daily from Miami. The United States dependency on foreign countries for continued PPE supplies is a business problem we are trying to become a major player in solving.”
For more information visit us at www.hawkeyesystemsinc.com